Groundbreaking trial tests novel Cancer-Fighting pill that supercharges immune cells
NCT ID NCT05858164
Summary
This early-stage study tested a new oral drug called BAY2862789 in 45 people with advanced solid tumors that had stopped responding to standard treatments. The drug works by activating the body's own immune T-cells to fight cancer. Researchers primarily wanted to determine safe dosage levels, understand how the drug moves through the body, and check for any early signs that tumors might shrink.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth medical Group Oncology Research at Celebration
Celebration, Florida, 34747, United States
-
Asan Medical Center - Oncology Department
Seoul, Seoul Teugbyeolsi, 05505, South Korea
-
Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit
Detroit, Michigan, 48202, United States
-
Cancer Center and Research Institute - UMMC
Jackson, Mississippi, 39213, United States
-
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, 28644, South Korea
-
Gyeongsang National University Hospital
Jinju, Gyeongsangnam-do, 52727, South Korea
-
Hadassah Hebrew University Hospital Ein Kerem
Jerusalem, 9112001, Israel
-
Hospital Universitari Vall d'Hebron - Institut d'Oncologia - Grupo de Tumores Toracicos y Cancer de Cabeza y Cuello
Barcelona, 08035, Spain
-
Hospital Universitario Virgen De La Victoria - Oncology
Málaga, 29010, Spain
-
Jilin Cancer Hospital
Changchun, Jilin, 130000, China
-
Princess Alexandra Hospital Australia
QLD, Queensland, 4102, Australia
-
START | San Antonio
San Antonio, Texas, 78229, United States
-
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi, 3080, South Korea
-
Tel-Aviv Sourasky Medical Center
Tel Aviv, 6423906, Israel
-
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, 06591, South Korea
-
The Kinghorn Cancer Centre - Medical Oncology Department
Darlinghurst, New South Wales, 2010, Australia
-
The University of Texas MD Anderson Cancer Center - Texas Medical Center
Houston, Texas, 77030, United States
-
Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech.
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.